Erbitux Shows Survival Benefit With Chemo In First-Line Metastatic Head & Neck Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
ImClone/Bristol will discuss potential for submitting an sBLA for the indication with FDA.